ArticleAnnals of hematology2025

Developmental stage modulates the prognostic impact of RAS pathway mutations in AML patients undergoing Allo-HSCT.

Xiaolin Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.